Aviso: Este sitio agrega datos públicos oficiales de la FDA, ClinicalTrials.gov, PubMed y SEC EDGAR solo como referencia general. No constituye asesoramiento médico, diagnóstico, recomendaciones de tratamiento ni asesoramiento de inversión.

PubMed

Radiation Oncology Device Recalls (2015-2025): Software and Artificial Intelligence as Emerging Drivers of Postmarket Safety.

PMID: 42752054 ·

M, a, r, i, a, m, , R, o, w, e, ;, , D, y, l, a, n, , R, o, w, e

RevistaPractical radiation oncology
Año
PMID42752054

Resumen

Radiation oncology (RO) relies on complex devices spanning simulation, planning, delivery, and verification, making postmarket surveillance critical. Prior analyses of U.S. Food and Drug Administration (FDA) recalls (2002-2015) demonstrated a high recall burden, predominantly driven by software-related failures. Following recent technological advances, including rapid expansion of software systems and artificial intelligence (AI)-enabled tools, we analyzed RO device recalls from 2015 to 2025 to

Fuente oficial

Ver en PubMed →

Datos obtenidos de PubMed / NCBI. Para consultar el texto completo y la información más reciente, remítase siempre al registro oficial.

↑